课题基金 / 基金详情

Establishment of murine model for auto immune hepatitis (AIH)

Establishment of murine model for auto immune hepatitis (AIH)
自身免疫性肝炎(AIH)小鼠模型的建立
批准号:
14570523
负责人:
OKUMURA Akihiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

OKUMURA Akihiko的其他基金

相似基金

相关文献

中文摘要
翻译
背景:用LKM-1抗体的靶分子人P450IID6(CYP2D6)免疫小鼠,建立小鼠肝炎模型。在本研究中,我们利用我们的小鼠肝炎模型,研究了AIH中肝细胞损伤的机制,包括T-reg的动态变化。材料和方法:8周龄C57BL/6雄性小鼠用β-GAL-CYP2D6融合蛋白(0.1mmol.1Mol)免疫C57BL/6雄性小鼠。μ-GAL融合蛋白为β-GAL-CYP2D6。每周检测血清ALT、抗-CYP2D6水平及肝脏组织学改变,直至免疫后4周。收集肝脏浸润性淋巴细胞(LIL)和脾细胞(SP),用抗CD8-PE和抗CD8-FITC或抗CD25-FITC联合染色,FACS流式细胞仪检测1×10~(-4)细胞数,用Cell Quest软件进行统计分析。结果:丙氨酸氨基转移酶在免疫后2周达高峰,4…时恢复正常β-GAL-CYP2D6免疫组小鼠的免疫时间延长。组织学观察,β-Gal-CYP2D6免疫组小鼠肝脏门脉周围炎性细胞浸润,小叶局灶性坏死灶。用LIL进行FACS分析,免疫后1周,CD4/CD8比值下降,与ALT升高同步,随后随着ALT的消退而逐渐恢复。而应用SP后,CD_4/CD_8比值变化不大,提示在肝炎病程中SP和LIL中CD_4~+~+、CD_8~+~+T细胞的动态变化不同。SP患者外周血中CD4~+CD25~+T细胞(T-reg)的比例与LIL相似。免疫后1周,LIL中T-reg频率即下降,并逐渐回升至免疫前水平。免疫后2周,SP组T-reg下降速度较LIL慢,2周时降至最低,而后升高,与LIL相似。结论:β-Gal-CYP2D6免疫C57BL/6小鼠可引起肝脏炎症反应。流式细胞仪分析结果表明,肝炎患者肝组织中CD8~+T细胞占优势。此外,T-reg的频率在ALT水平的升高过程中发生了剧烈的变化,提示T-reg可能在肝炎的发病过程中起一定的作用。较少
英文摘要
Background : We established murine hepatitis model by immunizing mice with human P450IID6 (CYP2D6), the target molecule of LKM-1 antibody. In the present study, we investigated the mechanism of liver cell injury in AIH, including the dynamics of T-reg, using our murine hepatitis model. Materials and methods : Eight week old C57BL/6 male mice were immunized with β-gal-CYP2D6 (0.1μmol), the fusion protein of β-gal and CYP2D6, intraperitoneally. Serum levels of ALT and anti-CYP2D6, and histologic changes in the liver were tested weekly until 4 week after immunization. To determine the proportion of CD4^+-T cell, CD8^+-T cell, and T-reg, liver infiltrating lymphocytes (LIL) and splenocytes (SP) were collected, stained with anti-CD4-PE in combination with anti-CD8-FITC or anti-CD25-FITC, and run on FACS flow cytometer, collecting data on 1x10^4 cells, analyzed using Cell Quest software. Results : Serum ALT level reached the peak at 2 week after immunization and returned to normal level at 4 … More week in the mice immunized with β-gal-CYP2D6. Histologically, periportal infiltration of the inflammatory cells and focal necrosis in the lobule was observed in the livers of the β-gal-CYP2D6-immunized mice. When LIL were used for the FACS analysis, the ratio of CD4/CD8 decreased at 1 week after immunization, synchronized with the elevation of ALT levels, then recovered gradually in parallel with the resolution of ALT flare. When SP were used, however, the change of CD4/CD8 was marginal, indicating the different dynamics of CD4^+- and CD8^+-T cells in SP from that in LIL during the course of hepatitis. The frequency of CD4^+ CD25^+-T cell (T-reg) in SP were similar to LIL. The frequency of T-reg in LIL decreased immediately at 1 week after immunization, and gradually increased to the same level as pre-immunization. T-reg in SP decreased more slowly than that in LIL, reached minimum at 2 week after immunization, then increased similarly to T-reg in LIL. Conclusions : Immunization of C57BL/6 mice with β-gal-CYP2D6 resulted in inflammation in the liver. Our results using FACS analysis indicated the predominance of CD8^+T cells in the livers with hepatitis. Further, the frequency of T-reg changed drastically during the flare of ALT levels, implies the possibility that T-reg play some roles on the course of hepatitis. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of novel therapeutic approach through regulatory T cells (Tr) and dendritic cells (DCs) for the patients with autoimmune hepatitis (AIH)
  • 批准号:
    18590754
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2006
  • 负责人:
    OKUMURA Akihiko
  • 依托单位:
Roles of regulatory T cells (Tr) and dendritic cells (DCs) in the pathogenesis of autoimmune hepatitis(AIH)
  • 批准号:
    16590644
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2004
  • 负责人:
    OKUMURA Akihiko
  • 依托单位:
国内基金
海外基金
基于人工智能-生理药动学探究阿塞那平与CYP2D6底物的药物相互作用及个体化给药方案
  • 批准号:
    2025JJ80180
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    谢茜
  • 依托单位:
中药前胡中水合氧化前胡素代谢活化共价修饰CYP2D6致酶失活的机制研究
中药前胡中水合氧化前胡素代谢活化共价修饰CYP2D6致酶失活的机制研究
  • 批准号:
    82460812
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.00万元
  • 批准年份:
    2024
  • 负责人:
    刘英
  • 依托单位:
新型细胞色素P450 2D6(CYP2D6)变异体的功能及其酶动力学特征研究
  • 批准号:
    LTGC23H310001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    钱建畅
  • 依托单位: